Dr. Byron Ter Morshuizen

Byron Ter Morshuizen is a clinical researcher whose work centers on anticoagulation management and infection prevention in hospital settings. Publications in Clinical and Applied Thrombosis/Hemostasis and the Wits Journal of Clinical Medicine reflect engagement with applied clinical research addressing therapeutic monitoring and frontline healthcare practices.

Research on anti-Xa monitoring of apixaban demonstrates expertise in coagulation science, laboratory diagnostics, and evaluation of direct oral anticoagulants in venous thromboembolism and atrial fibrillation. This work highlights strengths in translational research, inter-laboratory validation, and the assessment of therapeutic effectiveness in real-world clinical contexts.

Earlier work examining infection control practices during the SARS-CoV-2 pandemic underscores an interest in public health preparedness, clinical governance, and practitioner behavior in high-risk environments. Based on a limited number of available publications, the profile indicates a focus on improving patient safety through evidence-based evaluation of both pharmacologic therapies and hospital infection control strategies.